Pathology
Prognostic Protein Biomarker Found for Esophageal Adenocarcinoma
Podocalyxin-like protein (PODXL) is a cell surface transmembrane glycoprotein, the expression of which has been associated with poor prognosis in a range of malignancies including glioblastoma multiforme, breast cancer, bladder cancer, periampullary and pancreatic adenocarcinoma and colorectal cancer. More...31 Aug 2016
Study Highlights Importance of Regular Lung Cancer Screenings for Higher Risk Patients
Researchers have found that patients who tested negative for lung cancer (LC) in an LDCT (low-dose helical computed tomography) screening, but later went on to develop lung cancer within the following two years, had poorer outcomes than patients who initially had a non-cancerous positive screen test result. More...29 Aug 2016
Epigenetic Similarity in Cancer Cells Characterizes More Aggressive Tumors
Cancer researchers have found that the degree of epigenetic similarity among colorectal tumor cells was reflected in patients as significantly shortened relapse-free survival time and shortened time of overall survival. More...29 Aug 2016
Early Detection Identified for Leukemia Patients' Resistance to Therapy
A world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia has been made. The discovery offers some hope that the patients' treatment could be changed sooner to improve their chances of survival. More...25 Aug 2016
Parkinson's Disease Risk Indicators Found in Diverse Tissues
Tiny changes in DNA that have been linked to Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer's, were found not only in brain cells, where they were expected, but also in liver, fat, immune and developmental cells. More...18 Aug 2016
Biomarker of Aggressive Prostate Cancer Discovered
The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread and this will aid future clinical tests to help doctors decide how best to treat prostate tumors. More...18 Aug 2016
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit
New
PSA Test
Human Semen Rapid Test
In Other News
High Plasma Cortisol Levels Associated with Global Cognition Deterioration
Particle Size Not Cholesterol Determines Capacity of HDL to Reduce CVD
Novel Gene Discovered for Hereditary Colon Cancer
Gene Testing Simplified for Women with Ovarian Cancer
Gene Panel Predicts Damage in Donated Kidneys
Liquid Biopsies Offer New Hope for Treatment and Tracking of Ovarian Cancer
Genetic Mutations Linked to Rare Multiple Bowel Tumors
New Methods Detect Early Onset of Alzheimer's Disease
Bacterial Infection Identified as Cause of Overactive Bladder Syndrome
Simple Method Developed to Characterize Immune Cells in Tumors
New Genetic Mutation Linked to Osteonecrosis of the Hip
AI Approximates Human Performance in Breast Cancer Diagnosis
Aggressive Breast Cancer Identified with Fluorescent Technique
Persistent HPV Infection Raises Risk of Anogenital Cancers
Parkinson's Disease Biomarker Found in Urinary Samples
Benign Tissue Structural Features Predict Risk of Prostate Cancer Recurrence Following Surgery
Detection of Circulating Tumor DNA Predicts Colon Cancer Recurrence
Heart Transplantation Recipients Unaffected by Donor Troponin Levels
Genetic Causes of Bowel Cancer Clarified
Likely Flaws Uncovered for LM-Method for Lyme Disease Detection
Urine Protein Panels Identify Prostate Cancer and Differentiate between Tumors
Spatial Transcriptomics Technique Enables Visualization of Gene Expression in Tissues
Breast Tumors That Display Kataegis Have a Better Prognosis
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.